Showing results (91-100 of 101) with videos related to
Sort By:
Pageof 11
Medchemcomm|November 2, 2019
Exploration of [2 + 2 + 2] cyclotrimerisation methodology to prepare tetrahydroisoquinoline-based compounds with potential aldo-keto reductase 1C3 target affinityAna R N Santos, Helen M Sheldrake, Ali I M Ibrahim, et al.Journal of Medicinal Chemistry|June 4, 2015
Discovery of Multitarget Antivirals Acting on Both the Dengue Virus NS5-NS3 Interaction and the Host Src/Fyn KinasesPaolo Vincetti, Fabiana Caporuscio, Suzanne Kaptein, et al.European Journal of Medicinal Chemistry|September 8, 2017
Hydroxytriazole derivatives as potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitors discovered by bioisosteric scaffold hopping approachAgnese C Pippione, Alessandro Giraudo, Davide Bonanni, et al.European Journal of Medicinal Chemistry|June 26, 2018
Discovery and development of novel salicylate synthase (MbtI) furanic inhibitors as antitubercular agentsLaurent R Chiarelli, Matteo Mori, Daniela Barlocco, et al.European Journal of Medicinal Chemistry|March 31, 2018
Potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitors based on the benzoisoxazole moiety: application of a bioisosteric scaffold hopping approach to flufenamic acidAgnese Chiara Pippione, Irene Maria Carnovale, Davide Bonanni, et al.ACS Medicinal Chemistry Letters|April 19, 2019
Bioisosteres of Indomethacin as Inhibitors of Aldo-Keto Reductase 1C3Marco L Lolli, Irene M Carnovale, Agnese C Pippione, et al.Journal of Medicinal Chemistry|June 26, 2018
Targeting Myeloid Differentiation Using Potent 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase InhibitorsStefano Sainas, Agnese C Pippione, Elisa Lupino, et al.Journal of Medicinal Chemistry|April 12, 2021
Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold: SAR of the Biphenyl MoietyStefano Sainas, Marta Giorgis, Paola Circosta, et al.Journal of Medicinal Chemistry|September 26, 2022
Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold: SAR of the Aryloxyaryl MoietyStefano Sainas, Marta Giorgis, Paola Circosta, et al.Molecules (Basel, Switzerland)|January 8, 2020
Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes-6Jean Jacques Vanden Eynde, Arduino A Mangoni, Jarkko Rautio, et al.Pageof 11